Inconsistency between the Circulatory and the Brain Criteria of Death in the Uniform Determination of Death Act
World Allergy Organization Anaphylaxis Guidance 2020
The document titled “World Allergy Organization Anaphylaxis Guidance 2020” is a comprehensive guide addressing the increasing incidence of anaphylaxis and the need for up-to-date knowledge and management strategies for healthcare professionals. The World Allergy Organization’s (WAO) guidance, which builds on their 2011 guidelines, emphasizes the necessity of immediate, appropriate response to anaphylaxis, the most severe form of allergic reaction.
Key points include:
- Intramuscular epinephrine remains the first-line treatment, though its use is often suboptimal.
- After an anaphylactic episode, patients should be referred to specialists to identify triggers and learn preventive measures and self-management techniques.
- Challenges such as the limited availability and affordability of epinephrine auto-injectors across various countries are highlighted.
The guidance details diagnostic criteria for anaphylaxis, emphasizing that severe symptoms may occur in one organ system only and that multi-organ involvement is not necessary for diagnosis. The document also covers the global incidence of anaphylaxis, showing significant variations by region and age, with an overall low mortality rate but a high chance of recurrence.
Management strategies include the importance of allergy testing based on patient history and local allergen prevalence. The guidance also revises and simplifies the diagnostic criteria to aid healthcare providers in accurate and swift identification of anaphylaxis.
The document’s main objective is to enhance global awareness of anaphylaxis management and prevention, aiming to reduce the occurrence of severe outcomes and fatalities, especially in regions lacking specific national guidelines.
Please complete the Quiz in order to obtain your CPD points
